Compare DMRA & LZB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DMRA | LZB |
|---|---|---|
| Founded | 2011 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2020 | 1994 |
| Metric | DMRA | LZB |
|---|---|---|
| Price | $22.10 | $31.01 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 2 |
| Target Price | ★ $46.78 | $41.00 |
| AVG Volume (30 Days) | 478.7K | ★ 482.5K |
| Earning Date | 11-04-2026 | 11-17-2026 |
| Dividend Yield | N/A | ★ 3.02% |
| EPS Growth | ★ 121.48 | 5.11 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $2,349,433,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.55 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $16.50 | $28.39 |
| 52 Week High | $34.89 | $44.90 |
| Indicator | DMRA | LZB |
|---|---|---|
| Relative Strength Index (RSI) | 49.17 | 47.25 |
| Support Level | $18.03 | $28.59 |
| Resistance Level | $22.27 | $34.09 |
| Average True Range (ATR) | 1.83 | 0.97 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 30.13 | 26.38 |
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.
La-Z-Boy Inc is a world'wide producer of reclining chairs and one of the manufacturers/distributors of residential furniture in the United States. It manufacture, market, import, export, distribute and retail upholstery furniture products. In addition, it import, distribute and retail accessories and casegoods (wood) furniture products. Its reportable operating segments include the Retail segment and the Wholesale segment. Its Retail segment mainly sells upholstered furniture. Wholesale segment manufactures and imports upholstered and casegoods (wood) furniture and sells directly. The company generates majority of revenue from Wholesale segment which manufactures and imports upholstered furniture, such as recliners and motion furniture, sofas, loveseats, chairs, sectionals, modulars, etc.